PeriGen, Inc.
Perinatal monitoring software platform for standardizing and optimizing childbirth care workflows
- Sector
- Digital health
- Headquarters
- PRINCETON, NJ
- Latest Form D
- $6.4M, Mar 2013
- Total capital
- $11M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $11M
- 2 Form D · last Mar 2013
- 164 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 5
- 2 pending · first 2014
- Rank in peer group#13 of 197
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$6.4M
- Private capital raisedForm D · SEC · 1st filing$4.6M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 197 peers
Line = medianDigital health · Software
- Granted patents#13 · top 7%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Alan E. LefkowitzExecutive OfficerNamed in SEC Form D filings
- C. Richard StaffordDirectorNamed in SEC Form D filings
- David John AzadDirectorNamed in SEC Form D filings
- David John JahnsDirectorNamed in SEC Form D filings
- Donald A. DeiesoExecutive Officer, DirectorNamed in SEC Form D filings
- John E. CoatsExecutive OfficerNamed in SEC Form D filings
Show all 15 people
- John A. MoragneDirectorNamed in SEC Form D filings
- John A. ReardonDirectorNamed in SEC Form D filings
- Mark Richard NealDirectorNamed in SEC Form D filings
- Matthew John SappernExecutive Officer, DirectorNamed in SEC Form D filings
- Michael John PrittsExecutive OfficerNamed in SEC Form D filings
- Richard A. StaffordDirectorNamed in SEC Form D filings
- S. Joshua LewisDirectorNamed in SEC Form D filings
- Thomas E. Marren, Jr.Executive OfficerNamed in SEC Form D filings
- W. John CoatsExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 5 granted of 7- PendingMethod And System For Concurrently Monitoring Multiple Obstetrics PatientsUSPTOApplication 18651093
- GrantedMethod And System For Concurrently Monitoring Multiple Obstetrics PatientsUSPTOUS 12,033,752
- PendingMethod And System For Concurrently Monitoring Multiple Obstetrics PatientsUSPTOApplication 18123648
Show all 7 patent records
- Method And System For Concurrently Monitoring Multiple Obstetrics PatientsAug 22, 2024 · Application 18651093Pending
- Method And System For Concurrently Monitoring Multiple Obstetrics PatientsJul 9, 2024 · US 12,033,752Granted
- Method And System For Concurrently Monitoring Multiple Obstetrics PatientsJul 20, 2023 · Application 18123648Pending
- Method And System For Concurrently Monitoring Multiple Obstetrics PatientsAug 30, 2022 · US 11,430,568Granted
- Method And System For Concurrently Monitoring Multiple Obstetrics PatientsApr 13, 2021 · US 10,978,202Granted
- Method And Apparatus For Providing Contraction Information During LabourDec 1, 2020 · US 10,854,332Granted
- Method And Apparatus For Providing Information Related To Labor Progress For An Obstetrics PatientOct 28, 2014 · US 8,870,793Granted
Related companies, and why
- Vironix Health Inc.Similar federal contract value in Digital health · null in contracts
- Nuance Health, LLCSimilar federal contract value in Digital health · null in contracts
- KAI TECH LLCSimilar federal contract value in Digital health · null in contracts
- ATTUNE RTDSimilar federal contract value in Digital health · null in contracts
- AIBERRY INC.Similar federal contract value in Digital health · null in contracts
- Phenomics Health Inc.Similar federal contract value in Digital health · null in contracts
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .